Arcellx (ACLX) Other Non-Current Liabilities (2021 - 2025)

Arcellx's (ACLX) quarterly Other Non-Current Liabilities came in at $3.4 million in Q1 2025, down 77.78% year-on-year from $15.5 million in Q1 2024, and down 60.0% quarter-over-quarter from $8.6 million in Q4 2024.

Arcellx (ACLX) Other Non-Current Liabilities (2021 - 2025) Analysis & Trends

Arcellx's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $3.4 million for Q1 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 77.78% year-over-year to $3.4 million in Q1 2025; TTM through Mar 2025 was $3.4 million, a 77.78% decrease from a year earlier, with the FY2024 full-year figure at $8.6 million, changed N/A from the prior year.
  • Other Non-Current Liabilities eased to $3.4 million in Q1 2025 per ACLX's latest filing, from $8.6 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $15.5 million in Q1 2024 and bottomed at $117000.0 in Q2 2022.
  • The 4-year median for Other Non-Current Liabilities is $6.0 million (2024), against an average of $7.2 million.
  • Biggest YoY gain for Other Non-Current Liabilities was 77.78% in 2025; the steepest drop was 77.78% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $178000.0 in 2021, then plunged by 34.27% to $117000.0 in 2022, then soared by 7244.44% to $8.6 million in 2024, then sank by 60.0% to $3.4 million in 2025.
  • Per Business Quant, the three latest ACLX Other Non-Current Liabilities figures stand at $3.4 million (Q1 2025), $8.6 million (Q4 2024), and $15.0 million (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Arcellx 6.48 Bn 6.48 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2025 3.44 Mn
Dec 31, 2024 8.59 Mn
Sep 30, 2024 15.05 Mn
Jun 30, 2024 14.90 Mn
Mar 31, 2024 15.47 Mn
Jun 30, 2022 117,000.00
Mar 31, 2022 147,000.00
Dec 31, 2021 178,000.00